Copeptin Reflect Left Ventricular Systolic Function at Early Stage of Acute Myocardial Infarction in a Pig Model
Open Access
- 1 January 2023
- journal article
- research article
- Published by SAGE Publications in Biomarker Insights
- Vol. 18
Abstract
Introduction: Measurement of biomarkers early after acute myocardial infarction (AMI) might provide a cost-effective and widely available tool to assess infarct severity, myocardial dysfunction, and clinical outcomes. We aimed to induce AMI in miniature pigs, measure the levels of serum biomarkers and global LV function dynamically and explore the release kinetics and optimal sampling time points of copeptin and its correlation with global LV function. Methods: We induced AMI in the experimental group using a closed-chest model. Left ventricular (LV) function was detected by dual-source computed tomography (DSCT) and serum copeptin was determined by ELISA. Results: The serum copeptin levels were increased at 1 hour, peaked at 3 hours, gradually decreased after 6 hours, and returned to baseline 3 days after AMI. At 3 to 6 hours, the copeptin cutoff of 16.97 to 17.44 pmol/l had 100% sensitivity and 100% specificity ( P ⩽ .001) for AMI. Serum copeptin levels at 3 hours and 3 days were negatively correlated with the 3-hours LVEF ( P ⩽ .001), respectively. Conclusion: Serum copeptin levels change in time, and measurements at 3 to 6 hours after AMI had the highest predictive value.Keywords
Funding Information
- Health and Technology Program of Yunnan (2014NS261)
- Technology Program of Yunnan (202001AY070001-125)
This publication has 32 references indexed in Scilit:
- Copeptin for rapid rule out of acute myocardial infarction in emergency departmentInternational Journal of Cardiology, 2013
- Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarctionHeart, 2013
- Release Kinetics of Copeptin in Patients Undergoing Transcoronary Ablation of Septal HypertrophyClinical Chemistry, 2013
- Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery diseaseInternational Journal of Cardiology, 2012
- Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospitalVascular Health and Risk Management, 2011
- Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarctionClinical Research in Cardiology, 2011
- C-Terminal Provasopressin (Copeptin) is Associated With Left Ventricular Dysfunction, Remodeling, and Clinical Heart Failure in Survivors of Myocardial InfarctionJournal of Cardiac Failure, 2008
- Epidemiology of Myocardial InfarctionMedical Clinics of North America, 2007
- Sixty-four-slice CT in the assessment of global and regional left ventricular function: Comparison with MRI in a porcine model of acute and subacute myocardial infarctionEuropean Radiology, 2007
- C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial InfarctionCirculation, 2007